When someone is diagnosed with cancer, the treatment clock starts immediately. Every day matters. And increasingly, the most effective treatments require one thing that takes weeks to obtain from scratch: the patient's complete genome.
Personalized cancer treatment — including mRNA vaccines, targeted therapies, and immunotherapy drug selection — requires comparing the tumor's DNA against the patient's healthy baseline genome. If that baseline doesn't exist, it has to be sequenced from scratch. That process takes 3-6 weeks. In a cancer scenario where median survival might be months, those weeks are precious.
Designing a personalized cancer vaccine also requires knowing the patient's MHC profile to predict which tumor fragments the immune system can recognize. MHC typing adds additional time to the workflow. With a pre-stored genome that includes MHC data, this entire step collapses to a database lookup.
Sequencing your genome today costs $199 and takes minutes of your time. Not having it when you need it costs weeks of treatment delay during the most critical period of your life. The math is simple — and it's the reason oncologists increasingly recommend proactive genome sequencing for patients with family history of cancer.
Related: MHC Typing Explained · Genome Readiness for Families · View Pricing
Ready to secure your genome?
Join the Waitlist